We are PharmaSens
We at PharmaSens are devoted to simplifying diabetes management. We are passionate about technology bringing more people with diabetes towards better treatment and a life with increased freedom.
Our devices are developed with the highest quality standards in engineering. We know that perfect performance is of life-saving importance.
We are PharmaSens
We are a privately held Swiss company, located in Biel.
We involve users early and constantly in our development.
We have an expert team experienced in developing and bringing products to market for people living with diabetes.
We have strong collaborations and valuable partnerships with the medical device/pump development and manufacturing community.
We hold several granted patents, have pending applications and guaranteed freedom to operate for our technologies.
Meet the team
Marcel Both
Chief Executive Officer
- CEO experience from five different companies
- Insulin pump development and launch
- Combination product development and launch
- Degree in Electrical Engineering
Nicole Bernini
Product Management & Marketing
- 20 years in product management and project marketing
- Insulin pumps, continuous glucose monitoring, combination systems
- Disetronic Medical Systems, Roche Diabetes Care, yband AG
- Degree in Business Management / Marketing
Anna Martensson
Business Development & Project Management
- +20 years in medical devices
- Business and product development, project management
- J&J, Vitrolife, Decomplix, Biosafe (now Cytiva)
- Degree in Mechanical Engineering
Gilbert Schiltges
Product Development
- 19 years R&D leadership experience
- 13 years experience in R&D medical devices
- LEGO, Roche, Meyer Burger, Bystronic
- PhD in Mechanics
Thomas Moeller
Chief Financial Officer
- More than 30 years of finance experience
- 21 years of Venture Capital experience
- Executed 22 Investments/Exits and raised 4 Venture Funds in Life Science
- Degree in Economics and certified accountant
Serge Hügli
Industrialisation & Manufacturing
- 20 years in industrialization of industrial and medical products
- Insulin pump and accessories launch
- Disetronic, Roche, Staufen Inova
- Degree in Mechanical Engineering and Business Administration (EMBA)
Andrea Schütz Frikart
Human Factors & Usability
- 20 years in medical devices
- Development, regulatory and user safety
- Roche Diabetes Care, Swissmedic, medHF AG, Frikart GmbH and Confinis AG
- Degree in Biotechnology and Human Factors
Kurt Friedli
Hardware & Software Development
- More than 30 years in the development and manufacturing of single fault safe, reliable, and robust infusion and insulin pumps
- Disetronic Medical System, Roche Diabetes Care
- Degree in Electrical Engineering and Business Administration
David Teutsch
Product Development
- 17 years in medical devices
- Technology and product development
- Roche, Ypsomed, Phonak, Comet AG
- Degree in Microtechnology
Andreas Walter
Product Development
- 7 years in medical devices, 10 years in R&D
- Product development and global product launch
- Komax, Gambro (now Baxter), Medela
- Degree in Life Science Technologies and Polymer Engineering
Joanna Bitterli
Sensor Technology
- 14 years in research and industry
- Federal Institute of Technology, Swiss Center for Electronics and Microtechnology, Veolia
- PhD in Nanobiotechnology
Radek Skupienski
Sensor Technology
- More than 10 years in research and industry
- Federal Institute of Technology, Lausanne University Hospital, BASF
- Degree in Chemistry, PhD in Neuroscience
Adrian Auderset
Product Development
- 20 years in medical device
- Innovation and product development
- Switzerland Innovation Park, Cendres+Métaux
- Degree in Engineering and Innovation
Catherine Destribois
Laboratory Technician
- More than 20 years in a medical laboratory in diabetology and nephrology hospital department
- 5 years in management, production and quality control in a Swiss Red Cross blood bank
- Degrees in Biomedical Analysis and Medical Coding
Caroline Bernhard
Executive Assistant
- 20 years in hotel and tourism business
- Administration, marketing and human resources
- Hotel management experience
- Degree in hotel management, administration and education
Scientific Advisory Board
Julia Mader
Julia Mader is Associate Professor of Medicine at the Division of Endocrinology and Diabetology at Medical University of Graz and Deputy Head of the Diabetes Outpatient Clinic. Her research focuses on diabetes technology with emphasis on insulin pumps, continuous glucose monitoring, automated insulin delivery systems and decision support systems.
Lutz Heinemann
Lutz Heinemann is a member of national and international diabetes associations. He also sits on the Scientific Advisory Boards of various pharmaceutical and diagnostics companies. Since 2011, he has been the Managing Editor of the Journal of Diabetes Science and Technology. Professor Heinemann’s research is focused on insulin pharmacology and diabetes technology.
Pierre-Yves Benhamou
Pierre-Yves Benhamou is Professor of Endocrinology and Metabolism at University Hospital Grenoble Alpes, France, and an endocrinologist with a main clinical focus on type 1 diabetes, namely cell therapy, islet transplantation and innovative technologies. Professor Benhamou is also appointed chief medical officer at Diabeloop SA in the field of automated insulin delivery systems.
Guido Freckmann
Guido Freckmann is Medical Director and CEO of The Institute for Diabetes Technologies (IfDT) at the Ulm University, Germany. IfDT is an independent organization specialized on clinical research in the area of the testing of systems for continuous glucose monitoring (CGM) and insulin pumps. Dr. Freckmann has more than 20 years experience in advanced studies of medical devices for diabetes therapy.
Kirsten Nørgaard
Kirsten Nørgaard is heading the research group Diabetes Technology Research at Steno Diabetes Center Copenhagen, Denmark and an active clinician focusing on adults with type 1 diabetes at the the clinic serving 11,000 patients. She is a professor at University of Copenhagen, and has for years provided education courses for patients, students, and health care professionals nationally and internationally in the use of diabetes technology. Her research interest is broadly within optimal treatment possibilities for type 1 and type 2 diabetes using different types of technologies.
Board of Directors
Dr. Jean Patricot
Chairman
Dr. pharm. Former Director EMEA at Johnson & Johnson. More than 20 years of managerial experience in the diabetes area, as General Manager of LifeScan (blood glucose monitoring systems) and Head of OUS markets for Animas (insulin pumps), member of the global management board.
Prof. Urs A. Meyer
Vice-Chairman
Medical Doctor, Professor em. of Pharmacology, Biozentrum, University of Basel, Switzerland. Former Chairman of the Biozentrum. Extensive experience as advisor to organizations (WHO,INH,FDA) and companies in the field of biotechnology, drug development and medical devices in relation to personalized and precision medicine.
Prof. Peter Diem
Board member
Medical Doctor, Professor em. of Endocrinology, Diabetes & Nutrition, University Hospital Berne, Switzerland. President of diabetesschweiz (Swiss Diabetes Association, www.diabetesschweiz.ch). Major expertise in the optimization of the individualized care of persons with diabetes.
Dr. Paul Hadváry
Board member, Founder of Pharmasens AG
Dr. sc.nat. ETHZ. Career in Pharma R & D, including Medical Devices, Hoffmann - La Roche, Basel, Switzerland. Former CEO Basilea Pharmaceutica, Basel.
Sujay Ajit Karsandas Hamlai
Board member
MBA (Western Michigan University, USA). Owner and Managing Director, Al Bahja Group, Oman.
Dr. Gerardus (Gert) Adrianus Hoogland
Board member
Medical Doctor, MBA (INSEAD). CEO of HealthCrest AG, Zug , Switzerland. Formerly founder and CEO of Pharmaplan Pty Ltd., Executive Director of Litha Pharma Pty Ltd, and of Schering AG in South Africa.
Dr. Sandro Matter
Board member
Dr.sc.techn. ETHZ. >25 year industry career in Medical Technology with Stratec Medical AG (later Synthes AG, today J & J). Co-founder of Kuros Therapeutics AG, followed by Institute Straumann Executive Vice-President of the management board, Dentalpoint AG, Nobel Biocare AG / Danaher as Vice-President and part of the leadership team responsible for the Multibrand Strategy. Since 2021 entrepreneur in the MedTech field.